 |
|
|
|
 |
 |
Investigator |
|
Institution |
|
Project |
|
|
Keith Black, MD |
|
Cedars-Sinai |
|
Gene Profiling of Human Glial Tumors |
|
|
Charles Conrad, MD |
|
University of Texas,MD Anderson Cancer Center |
|
Preclinical Testing of Malignant Glioma Models
for Signal Transduction Inhibition and Cytotoxic Agents |
|
|
Alex Franzusoff, PhD |
|
University of Colorado |
|
Development of Novel Brain Tumor Vaccines |
|
|
William Pardridge,
MD |
|
University of California
Los Angeles |
|
New Approach to Gene Therapy for Brain Cancer |
|
|
John Park, MD |
|
University California
San Francisco |
|
Development of Novel Therapeutics to Brain Tumor Treatment |
|
|
Russell Pieper, PhD |
|
University California
San Francisco |
|
Intracranial Microinfusion of a Novel, Mechanism-Based
Drug Combination in the Treatment of Advanced GBM |
|
|
Jeremy Rich, MD |
|
Duke University |
|
Optimizing the Use of Signal Transduction Inhibitors for the Treatment of Gliomas |
|
|
James Rubenstein, MD PhD |
|
University California
San Francisco |
|
Inhibition of the Alpha-v Integrins in the Treatment of Glioblastoma |
|
|
John Sampson, MD PhD |
|
Duke University |
|
Development of a Clinical Vaccine for Malignant Gliomas |
|
|
Timothy Stenzel MD PhD |
|
Duke University |
|
Rational Selection of Small Molecules and Immunotoxin Therapy for Malignant Gliomas |
|
|
William Weiss MD,
PhD |
|
University California
San Francisco |
|
EGFRviii Induced Glioma, and Inhibitor Based Treatment Models |
 |
|
|
|
 |
